|
|
|
* - may be subscription-only |
|
|
- Aphios: Granted US Patent for Thermal Conversion
of CBDA and Other Carboxylic Acid Cannabinoids More
- Biophytis: Enters Exclusive Negotiations With a
Chinese Pharmaceutical Company to License BIO101 More
- BostonGene: Evaluates Novel Therapies and Immune
System Profiling as a Marker of Response in Patients
With Gastrointestinal Cancers More
- CardioFocus: Publication of 1-Year ECLIPSE AF
Clinical Trial Results More
- CereVasc: First Enrollment in STRIDE Clinical Trial
of the eShunt System for Normal Pressure Hydrocephalus
More
- Eterna Therapeutics: Positive Preclinical Study
Results on Lead Product ERNA-101 in Ovarian Cancer More
- Freudenberg Medical: CEO Transition More
- Inflammasome Therapeutics: Topline 3-month Data From
a Clinical Trial of Its First-in-Class Dual
Inflammasome Inhibitor, K8, in Geographic Atrophy,
Demonstrating Rapid, Substantial and Significant
Efficacy and Safety More
- Keros Therapeutics: Additional Update on the Phase 2
TROPOS Trial More
- Keylicon Biosciences: Secures Exclusive Rights to
Modified Self-Amplifying RNA Technology More
- MedTherapy: Innovative Global Measures to Meet Acute
Manufacturing Challenges for 'CAR-T' Cell Gene
Therapies to Make Them More Affordable and Accessible
Worldwide More
- Neurogen Biomarking: Collaboration With Linus Health
Bringing Easy Access to Cutting-Edge Technology to
Support Early Detection of Mild Cognitive Impairment
and Dementia Due to Alzheimer's Disease More
- Parabilis Medicines: Presents Updates on Clinical
Progress of β-cateninTCF4 Inhibitor, Helicon Portfolio
and Discovery Engine at J.P. Morgan Healthcare
Conference More
- PaxMedica: First Patent Allowance for Suramin
Intranasal Formulation in the treatment of Autism
Spectrum Disorder and Other Conditions More
- Simnova and Orna: Expand Strategic Partnership to
Include BCMA-Targeted RNA Therapeutics More
- Sinaptica: Initiation of Co-Development of the
SinaptiStim Precision Neuromodulation System to Treat
Alzheimer’s Disease; On Track for Pivotal Clinical
Trial Initiation in 2025 More
- TransCode Therapeutics: First Patient Dosed in Third
Cohort With Lead Candidate in Phase 1 Clinical Trial More
- Verastem Oncology: Names Matthew E. Ros as Chief
Operating Officer More
- Zai Lab: Positive Topline Results for TIVDAK in the
China Subpopulation of the Global Phase 3 innovaTV 301
Trial in Patients With Recurrent or Metastatic
Cervical Cancer More
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Allurion: Private Placement of Common Stock and
Preliminary Unaudited Financial Results for the Fourth
Quarter and Fiscal Year 2024 More
- Charles River Disappoints Investors With Damp
Outlook for 2025 More*
- 908 Devices: Preliminary Fourth Quarter and Full
Year 2024 Financial Results More
- Phio
Pharmaceuticals: $3.19 Million Registered Direct
Offering Priced At-the-Market Under Nasdaq Rules More
- Rapid Micro Biosystems: Preliminary Unaudited Fourth
Quarter and Full Year 2024 Revenue More
- Sarepta Bullish After Another Big Beat for Elevidys
More*
- Vericel: Preliminary 2024 Financial Results, 2025
Financial Guidance and Increased Mid-Term
Profitability Targets More
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Biogen Lays Out Three FDA Decisions That Could Ramp
Up Alzheimer’s Drug Launch More*
- CEO Bancel Says Moderna Was ‘Too Logical’ On
COVID-19 Vaccinations More*
- Join Big4Bio CBO Dave Whelan in Munich for DxPx;
Save With a Special Discount Code! More
- Moderna’s Noubar Afeyan: AI Could Solve Climate
Change More*
- Subscribe to LifeSci Startup for Updates on
US Startups More
- Wave Wants to
Put the Joy Back Into Weight-Loss Drugs More*
|
|
|
|
Section
Sponsor:
|
 |
|
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:Boston Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
|
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- OPPORTUNITY: Senior Director, Integrated Marketing
& Communications - Remote More
- OPPORTUNITY: Clinical Development Leader - New York,
NY More
- OPPORTUNITY: Sales Executive - Hybrid More
- OPPORTUNITY: Senior Director of Business Development
- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs - MA More
- OPPORTUNITY: Vice President of Sales &
Marketing, North America - Remote More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
